Catalyst Wire Dossier Catalyst Wire Dossier

Iressa (Gefitinib)

Gefitinib · AstraZeneca
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Iressa (Gefitinib), covering 2009-04-23 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone [Phase 1, Phase 2]

See pricing